New drug discovery targets relevant to neurodegenerative diseases

Projektinformationen

DRUGS IN NEURODEGENE

ID Finanzhilfevereinbarung: QLK6-CT-1999-50409

Projekt abgeschlossen

Startdatum 17 April 2001

Enddatum 16 April 2005

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 202 224,00

EU-Beitrag € 202 224,00

Koordiniert durch

SCHERING-PLOUGH SPA
Italy

Ziel

The aim of the project is to study neuroprotection in experimental models of human diseases. In particular we will study the effects of capsize inhibitors and that of cannabinoid receptor activity.

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

SCHERING-PLOUGH SPA

• EU-Beitrag: Keine Daten
• Adresse: via Olgettina 58 ; 20132 MILANO ; Italien
• Gesamtkosten: Keine Daten